Monosaccharides

4-Aminophlorizin is a chemical compound that inhibits the uptake of azide by red blood cells. It has been shown to be effective against intestinal parasites and trophozoites. 4-Aminophlorizin is a potent inhibitor of the membrane system, which may be due to its interaction with the semenza, or membrane protein.

2-epi-(-)-emtricitabine is an analog of the nucleoside cytidine, which inhibits the phosphorylation and subsequent degradation of deoxycytidine kinase, thereby blocking the production of the viral DNA polymerase. The compound also inhibits tyrosine kinases, which are enzymes that play a vital role in cell signaling. This inhibition may contribute to its antiviral activity. 2-epi-(-)-emtricitabine has been shown to inhibit human immunodeficiency virus (HIV) replication in vitro and in vivo. It is a prodrug that is converted to emtricitabine, its active form, by deoxycytidine kinase and then hydrolyzed by esterases. 2-epi-(-)-emtricitabine has been shown to be effective against hepatitis B virus and cancer cells.

Phenyl a-L-thiorhamnopyranoside is a monosaccharide that is synthesized by the methylation of alpha-D-glucose. It is a custom synthesis that is used in the synthesis of oligosaccharides, polysaccharides, and sugar drugs. Phenyl a-L-thiorhamnopyranoside can be fluorinated to create an active form that has antibacterial activity. This compound has shown no signs of toxicity in animal studies and has been used as a food additive.

Tetra-O-acetyl-2-acetamido-2-deoxy-b-D-mannose is a modified sugar that is synthesized by the methylation of 2,4,6-trichloroacetimidate. This compound has been used in the synthesis of glycosylations and other modifications. Tetra-O-acetyl-2-acetamido-2-deoxy-b-D mannose can be custom synthesized to your specifications with high purity.

N-Acetyl-L-neuraminic acid is a glycosylation compound that is an important component of the cell wall of Gram negative bacteria. It is used in the synthesis of polysaccharides and in the formation of complex carbohydrates. N-Acetyl-L-neuraminic acid has been studied for its potential use as a drug delivery agent due to its ability to inhibit the activity of enzymes such as α-mannosidase, which can lead to tumor metastasis. This compound can be synthesized using methylation, fluorination, and click chemistry, or custom synthesized by ordering specific monosaccharides. N-Acetyl-L-neuraminic acid can also be modified with acetate groups to create an acetylated form for use in chemical analysis or as a substrate for enzymatic reactions.

1,2,3,5,6-Penta-O-propanoyl-b-D-glucofuranose is a methylated sugar. It is a polysaccharide consisting of 1,2,3,5,6-penta-O-propanoyl-b-D-glucopyranosyl units linked by β-(1→4)-glycosidic bonds. This carbohydrate can be used in the synthesis of oligosaccharides and glycosylation reactions. 1,2,3,5,6-Penta-O-propanoyl b -D -glucofuranose has been fluorinated to give pentafluorobenzoyl b -D -glucofuranose which is used for click modification.

(2R,3R,4S,5R,6S)-3,4,5-Trihydroxy-2-hydroxymethyl-7,9-diaza-1-oxa-spiro[4,5]decane-10-one-8-thione is a custom synthesis of a polysaccharide. It has been modified to include fluorination and methylation. The monosaccharides present are glucose and galactose. This polysaccharide also has a saccharide linkage to an oligosaccharide that contains glycosylation sites for sugar groups.

This chemical is a custom synthesis of (-)-Lyoniresinol 9'-O-glucoside. The chemical is a modification of (-)-Lyoniresinol 9'-O-glucoside and fluorinated at the C2 position. It is also methylated on the C3 position. The chemical is synthesized by click chemistry, which involves the use of copper(II) ions as catalysts to generate covalent bonds between two molecules. This chemical has been shown to be an oligosaccharide with saccharide chains that are linked together by glycosylation. There are six sugar residues in this compound: glucose, galactose, rhamnose, xylose, glucuronic acid, and mannitol. This compound has CAS number 143236-02-6 and molecular weight of 881.5 g/mol (CAS No.).

Methyl D-arabinofuranoside is an antimycobacterial agent that inhibits the synthesis of mycolic acids, which are important components of the cell wall of Mycobacterium tuberculosis. Methyl D-arabinofuranoside has been shown to be active against drug-resistant strains and has been well tolerated by animals. This compound can be synthesized from 2,4-dichlorophenylacetic acid and arabinose in two steps. The first step involves a three-component condensation reaction with sodium hydroxide, hydrochloric acid, and 2,4-dichlorophenylacetic acid. The second step is a nucleophilic attack on the pyran ring of methyl D-arabinofuranoside with hypophosphorous acid. Methyl D-arabinofuranoside can also be prepared by reacting sodium nitrosobenzene with sodium benzene sulfinate in alcoholic solution

Glufosfamide is a cytotoxic drug that is used in the treatment of some types of cancer. It is a prodrug that requires conversion to its active form, glufosfamid, by esterase enzymes before it can exert its genotoxic effects. Glufosfamide has shown to be active against platinum-resistant ovarian cancer and solid tumours. This drug also has been shown to inhibit the growth of prostate cancer cells and miapaca-2 cells, which are derived from pancreatic cancer. Glufosfamide has been found to have low toxicity in mice, but there may be adverse reactions when combined with other drugs such as erythromycin or ketoconazole.

2,3,4,6-Tetra-O-benzoyl-b-D-glucopyranosyl isothiocyanate (TBG) is a fluorescent compound that has been shown to inhibit the activity of proteinase and other enzymes. TBG is also an inhibitor of human blood glucose levels. This compound is not chiral, but it can be used as a reagent for the production of chiral compounds. TBG binds to DNA with high affinity and specificity. It has been shown to act as a growth factor for some cancer cells by inhibiting the expression of p21 protein.

1,3,4,6-Tetra-O-acetyl-N-(4-methoxybenzylidene)-b-D-glucosamine is a high purity custom synthesis sugar that has been fluorinated and glycosylated. It is synthesized from the methylation of 4-(1,3,4,6-tetra-O-acetyl)-N-(4-hydroxybenzylidene)-b-D-glucosamine and can be used for the modification of saccharides or oligosaccharides. This compound has CAS No. 7597-81-1 and is known as a carbohydrate.

D-glucose 6-phosphate is an intermediate in the hexose monophosphate shunt pathway. It is formed by the enzyme phosphoglucomutase from D-glucose 1-phosphate and UTP. D-glucose 6-phosphate is also an important intermediate in glycolysis. The conversion of D-glucose 6-phosphate to glucose 1,6-bisphosphate occurs through a series of reactions catalyzed by enzymes that are sensitive to inhibition by magnesium ions. These reactions include the phosphofructokinase, hexokinase, and pyruvate kinase reactions. The accumulation of glucose 6-phosphate leads to increased levels of lactate production and decreased levels of ATP production. This may be due to its ability to inhibit monoamine reuptake, which would lead to decreased synthesis of dopamine and serotonin.

M-topolin-9-glucoside is a synthetic sugar that has been modified by the introduction of fluorine atoms at C-2, C-3, and C-4. This sugar is used to study the interactions between carbohydrates and proteins. It is also used for the synthesis of oligosaccharides as well as for glycosylation and methylation reactions. M-topolin-9-glucoside is a monosaccharide that has been glycosylated and methylated. It can be used as a replacement for glucose in some reactions due to its stability and low cost.

3,4,6-Tri-O-acetyl-1,2-O-ethoxyethylidene-a-D-fructopyranose is a modified carbohydrate with the chemical formula C 12 H 20 O 8 . It is a white crystalline solid that is soluble in water. 3,4,6-Tri-O-acetyl-1,2-O-ethoxyethylidene-a-Dfructopyranose can be used as a monosaccharide or an oligosaccharide. This compound has been synthesized by methylation and glycosylation of glucose.

Raltegravir b-D-glucuronide is a synthetic, fluorinated analog of raltegravir. It is a potent HIV-1 integrase inhibitor that has been shown to be active against the majority of HIV-1 strains. Raltegravir b-D-glucuronide is less potent than the parent compound and exhibits reduced antiviral activity in vitro. Raltegravir b-D-glucuronide is metabolized to raltegravir and eliminated in urine as the glucuronide conjugate.

3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-b-D-glucopyranosyl chloride is a modification of the carbohydrate. It is a complex carbohydrate that has been custom synthesized for research purposes. It can be used as a monosaccharide or polysaccharide in glycosylation reactions. This compound has not been fluorinated and the CAS number is 7772-87-4.

Ramipril acyl-b-D-glucuronide is a glycosylated prodrug that is the active form of ramipril, an ACE inhibitor. It is metabolized in the liver to ramipril and excreted in the urine. Ramipril acyl-b-D-glucuronide has been shown to have an increased bioavailability and a longer half-life than ramipril due to its glycosylation. The synthesis of this drug has been modified by methylation, fluorination, and saccharide modification. This compound is also available as a custom synthesis for research purposes with high purity.